Page last updated: 2024-08-17

carbostyril and Body Weight

carbostyril has been researched along with Body Weight in 89 studies

Research

Studies (89)

TimeframeStudies, this research(%)All Research%
pre-19905 (5.62)18.7374
1990's16 (17.98)18.2507
2000's34 (38.20)29.6817
2010's29 (32.58)24.3611
2020's5 (5.62)2.80

Authors

AuthorsStudies
Begnel, L; Litvin, M; Petersen, MC; Wallendorf, M1
Coppes, RP; Du, L; Gao, S; Li, F; Li, K; Liu, F; Luo, Y; Pan, Y; Yao, Z; Zhang, D; Zhang, H; Zhu, J1
Eriksson, H; Meehan, SR; Newcomer, JW; Weiss, C; Zhang, P1
Guimbellot, JS; Heltshe, SL; Jain, M; Jovanovic, B; Rowe, SM; Sagel, SD; Secunda, KE1
Chen, N; Feng, M; Guo, B; Huang, J; Li, X; Lin, D; Zhao, X; Zou, J1
Che, KK; Hu, CH; Li, DJ; Liu, L; Liu, XM; Yue, Q1
Blusch, A; Brunner, J; Ellrichmann, G; Fatoba, O; Gold, R; Hayardeny, L; Hayden, M; Reick, C; Saft, C; Sehr, D; Winklhofer, KF1
Crespo-Facorro, B; Díaz Martínez, Á; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suárez Pinilla, P; Vázquez-Bourgon, J1
Benchitrit, J; Drüeke, TB; Edelman, A; Galmiche, A; Guerrera, IC; Guillonneau, F; Ivanovski, O; Joki, N; Lacour, B; Lucas, A; Maizel, J; Marçon, F; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG; Phan, O1
Berk, M; Ghanizadeh, A; Sahraeizadeh, A1
Forbes, RA; Mankoski, R; Manos, G; Marcus, R; Marler, S; McQuade, R; Stockton, G1
Singh, KP; Tripathi, N1
Barry, PJ; Horsley, AR; Jones, AM; Webb, AK1
Buchanan, RW; Newcomer, JW; Weiden, PJ1
Liu, J; Meng, X; Xia, SY; Yu, H; Zhang, P; Zhang, YR1
Chen, QK; Lai, Y; Li, JY; Ouyang, H; Shan, TD; Xia, ZS; Yang, HS; Yu, T; Zhong, W1
Blier, P; Bundgaard, C; El Mansari, M; Oosterhof, CA1
Anamthathmakula, P; Sahu, A; Sahu, M1
Davis, J; Heltshe, SL; Higgins, MN; Niknian, M; Pace, J; Rowe, SM; Stalvey, MS; Tarn, V1
Carson, WH; Findling, RL; Forbes, RA; Ivanova, S; Iwamoto, T; Jin, N; Marcus, R; McQuade, RD; Nyilas, M; Robb, A1
Burnett, K; Chang, WY; Chen, Y; Griffiths, KN; Hogue, A; López, FJ; Mais, DE; Marschke, K; Meglasson, MD; Pedram, B; Shen, Y; Vajda, EG; van Oeveren, A; Zhi, L1
Terao, T1
Archibald, D; Carson, WH; Fleischhacker, WW; Marcus, RN; McQuade, RD; Swanink, R1
Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR1
Cho, SJ; Jang, JH; Kang, DH; Kim, YK; Kwon, JS; Yoo, SY1
Baker, RA; Kim, E; Meyer, JM; Rosenblatt, LC; Whitehead, R1
Berman, RM; Carlson, BX; Fava, M; Marcus, RN; Nelson, CJ; Pikalov, A; Qi, Y; Thase, ME; Tran, QV; Trivedi, MH; Yang, H1
Gebicke-Härter, PJ; Schmitt, A; Segnitz, N; Zink, M1
Englisch, S; Inta, D; Weinbrenner, A; Zink, M1
Kashima, H; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K1
Coffey, BJ; Goldman, R; Hirsch, S; Jummani, R; Lyon, GJ; Samar, S; Spirgel, A1
Hahn, SW; Ham, BJ; Kang, RH; Lee, HY; Lee, MS; Paik, JW1
Dewaele, P; Fleischhacker, WW; Heikkinen, ME; Hennicken, D; Kerselaers, W; Landsberg, W; Loze, JY; McQuade, RD; Olié, JP1
Bae, KY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS1
Lee, SY; Pae, CU; Park, MH; Patkar, AA1
Cohn, T; Faulkner, G; Mukundan, A; Remington, G1
Breton, C; Delahaye, F; Dickes-Coopman, A; Dutriez-Casteloot, I; Guillemot, J; Laborie, C; Lesage, J; Lukaszewski, MA; Mayeur, S; Montel, V; Vieau, D1
Hamer, RH; LaVange, LM; Lieberman, JA; McEvoy, JP; Nussbaum, AM; Perkins, DO; Ring, KD; Rosenheck, RA; Stroup, TS; Swartz, MS1
Berge, RK; Diéguez, C; Fernø, J; Fjær, S; López, M; Lunder, N; Pavlin, T; Skrede, S; Steen, VM; Vázquez, MJ; Vidal-Puig, A1
Diaz-Atienza, F; Gurpegui, M; Gutiérrez-Rojas, L; Jurado, D; Martínez-Ortega, JM1
Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME1
Azorin, JM; Gasquet, I; Gierski, F; Leguay, D; Lemogne, C; Limosin, F; Raucher-Chéné, D; Rouillon, F; Schuster, JP1
Chen, CK; Hsiao, CC; Huang, YS; Ree, SC; Wang, LJ1
Baker, RA; Carlson, BX; De Hert, M; Eudicone, JM; Fyans, P; Kemp, DE; Marler, SV; Rahman, Z1
Elsheikh, HA; Khalafallah, AI; Osman, IA; Taha, AA1
Ali, MW; Carson, WH; Ingenito, GG; Kane, JM; McQuade, RD; Saha, AR; Zimbroff, DL1
Glisson, JR; Hofacre, CL; Mathis, GF1
Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H1
Britt, CS; Daniels, AJ; Grizzle, MK; Ignar, DM; Jones, DN; Kalinichev, M; Rourke, C1
Baldessarini, RJ; Centorrino, F; Cimbolli, P; Cincotta, SL; Fogarty, KV; Salvatore, P; Sani, G; Thompson, TA1
Abou-Gharbia, N; Bourin, M; Carson, W; Iwamoto, T; Marcus, R; McQuade, R; Sanchez, R; Stock, E; Swanink, R; Vieta, E1
Abou-Gharbia, N; Carson, W; Impellizzeri, C; Iwamoto, T; Kaplita, S; Marcus, R; McQuade, R; Rollin, L; Sachs, G; Sanchez, R; Stock, E1
Borba, CP; Cather, C; Daley, TB; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Kunkel, L; Louie, PM; Nguyen, DD1
Aisaka, K; Kuraishi, Y; Maekawa, T; Nojima, H1
Duane, DD1
Harborne, GC; Karunakaran, K; Tungaraza, TE1
Chrzanowski, WK; Marcus, RN; McQuade, RD; Nyilas, M; Torbeyns, A1
Altshuler, LL; Frye, MA; Keck, PE; Leverich, GS; Martens, B; McElroy, SL; Post, RM; Stanford, K; Suppes, T1
Carson, WH; Daniel, DG; Marcus, RN; McEvoy, JP; McQuade, RD1
Haug, SR; Heyeraas, KJ; Ibrahim, SO; Raju, B1
Corey-Lisle, PK; Crosby, RD; Kan, HJ; Kolotkin, RL; McQuade, RD1
Bai, DS; Sea, HS; Seo, WS; Sung, HM1
Heath, H; Poulsom, R1
Aldred, KL; Burrell, LM; Hutchins, AM; Johnston, CI; Phillips, PA; Risvanis, J1
Kanno, Y; Okada, H; Saruta, T; Suzuki, H2
Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y1
Branstetter, DG; Hampton, LA; Linseman, DA1
Creveld, CV; Gavrielli, R; Glickman, A; Yagil, R; Ziv, G1
Ishibashi, S; Iwakura, K; Kawaminami, A; Shindo, Y; Sumi, N; Tawaratani, T; Uchimoto, H; Yoshida, M1
Kato, M; Miyamoto, M; Nomura, M; Shimoda, K; Sugawara, T; Takada, S; Yoshida, M1
Hamaguchi, A; Iwao, H; Kato, Y; Kim, S; Miura, K; Ohta, K; Shinkawa, T; Tsuchiya, N1
Brumbaugh, GW; Lizarraga, RE; Ocampo, CL; Sumano, LH1
Hashimoto, M; Makino, H; Mimura, Y; Ogura, T; Oishi, T; Otsuka, F; Yamauchi, T1
Hasimoto, K; Itoh, N; Owen, K; Takizawa, T; Yamashita, S1
Iki, K; Kido, A; Konishi, Y; Morishita, T; Motoyama, M; Takahama, M; Tamai, S; Tatsumi, K; Tsujiuchi, T; Tsutsumi, M1
Gunnarsson, A; Pedersen Mörner, A; Segall, T; Wallgren, P1
Carlotti, DN; Guaguere, E; Guiral, V; Jasmin, P; Pin, D; Thomas, E1
Aramayona, JJ; Bregante, MA; Fraile, L; Garcia, MA; Saez, P; Solans, C1
Honjo, S; Kawabata, K; Kohno, H; Murakami, M; Ota, T; Tanaka, T; Tsuda, H1
Chung, MK; Han, SS; Kim, JC; Shin, HC; Yun, HI1
Burrell, LM; Fraser, TB; Li, M; Turner, SW; Wen, C; Whitworth, JA1
Kyriakis, SC; Sarris, K; Tsiloyiannis, VK; Vlemmas, J1
Gupta, S; Huan, JN; Pal, R; Sahu, A; Zhao, AZ1
Art, T; Lekeux, P1
Higgins, C; McAnulty, PA; Tesh, JM; Tesh, SA; Wilby, OK; Willoughby, CR2
McAnulty, PA; Tesh, JM; Tesh, SA; Wilby, OK; Willoughby, CR1

Reviews

4 review(s) available for carbostyril and Body Weight

ArticleYear
Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:11

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Drug Substitution; Dyskinesia, Drug-Induced; Evidence-Based Medicine; Humans; Lipids; Olanzapine; Patient Outcome Assessment; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology

2013
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Dibenzothiazepines; Drug Substitution; Fasting; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Schizophrenia; Weight Gain

2010
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
    International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2012
[Antibiotics and overweight].
    Ugeskrift for laeger, 2005, May-23, Volume: 167, Issue:21

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin

2005

Trials

28 trial(s) available for carbostyril and Body Weight

ArticleYear
Changes in Metabolic Parameters and Body Weight in Patients With Major Depressive Disorder Treated With Adjunctive Brexpiprazole: Pooled Analysis of Phase 3 Clinical Studies.
    The Journal of clinical psychiatry, 2019, 10-01, Volume: 80, Issue:6

    Topics: Adult; Antidepressive Agents; Blood Glucose; Body Weight; Cholesterol; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Middle Aged; Quinolones; Thiophenes; Triglycerides

2019
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
    Psychopharmacology, 2018, Volume: 235, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Triglycerides; Young Adult

2018
A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
    Child psychiatry and human development, 2014, Volume: 45, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Treatment Outcome

2014
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:8

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones

2013
[Treatment of antipsychotic drug-induced phlegm dampness type amenorrhea by Wuji Powder and a small dose aripiprazole: a clinical study].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2014, Volume: 34, Issue:12

    Topics: Aged; Amenorrhea; Antipsychotic Agents; Aripiprazole; Body Mass Index; Body Weight; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Galactorrhea; Humans; Obesity; Piperazines; Quinolones; Waist-Hip Ratio

2014
Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.
    Pediatrics, 2017, Volume: 139, Issue:2

    Topics: Aminophenols; Body Height; Body Weight; Child; Cystic Fibrosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Quinolones; Treatment Outcome

2017
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.
    The American journal of psychiatry, 2008, Volume: 165, Issue:11

    Topics: Administration, Oral; Adolescent; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2008
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.
    Biological psychiatry, 2009, Mar-15, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Double-Blind Method; Electrocardiography; Female; Glucose; Humans; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quinolones; Schizophrenia

2009
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:18

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; Lorazepam; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Young Adult

2008
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:12

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Body Weight; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Quinolones; Treatment Outcome

2008
Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Weight; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome; Young Adult

2009
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.
    The international journal of neuropsychopharmacology, 2010, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Aged; Aripiprazole; Body Mass Index; Body Weight; Chemotherapy, Adjuvant; Cholesterol; Clozapine; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Schizophrenia; Treatment Outcome; Young Adult

2010
Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Size; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Female; Hip; Humans; Hyperprolactinemia; Liver Function Tests; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Waist Circumference; Wakefulness; Young Adult

2010
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
    The American journal of psychiatry, 2011, Volume: 168, Issue:9

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dibenzothiazepines; Diet, Reducing; Drug Substitution; Exercise; Humans; Hypercholesterolemia; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides

2011
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
    Journal of affective disorders, 2013, May-15, Volume: 148, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Piperazines; Quinolones; Time Factors; Treatment Outcome; Triazines; Valproic Acid

2013
Disposition kinetics of enrofloxacin (Baytril 5%) in sheep and goats following intravenous and intramuscular injection using a microbiological assay.
    Research in veterinary science, 2002, Volume: 73, Issue:2

    Topics: Animals; Anti-Infective Agents; Body Weight; Enrofloxacin; Fluoroquinolones; Goats; Half-Life; Injections, Intramuscular; Injections, Intravenous; Kinetics; Logistic Models; Male; Microbial Sensitivity Tests; Quinolones; Sheep

2002
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9

    Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Weight; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Female; Haloperidol; Humans; Hyperprolactinemia; Long QT Syndrome; Male; Piperazines; Placebos; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome

2002
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
    The British journal of psychiatry : the journal of mental science, 2005, Volume: 187

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome

2005
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Quinolones

2006
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
    Acta psychiatrica Scandinavica, 2006, Volume: 113, Issue:2

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Clozapine; Community Mental Health Centers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Schizophrenia; Triglycerides

2006
Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.
    Psychopharmacology, 2006, Volume: 189, Issue:2

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quinolones; Recurrence; Schizophrenia; Treatment Outcome; Triglycerides

2006
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
    Journal of psychiatric research, 2007, Volume: 41, Issue:11

    Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Weight; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Schizophrenia

2007
Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
    European psychiatry : the journal of the Association of European Psychiatrists, 2008, Volume: 23, Issue:8

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Dose-Response Relationship, Drug; Europe; Female; Humans; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Self Concept; Social Adjustment

2008
Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
    Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Body Mass Index; Body Weight; Child; Chronic Disease; Female; Humans; Male; Piperazines; Quinolones; Tics; Tourette Syndrome; Treatment Outcome

2008
Effect of water deprivation on the disposition kinetics of enrofloxacin in camels.
    Journal of veterinary pharmacology and therapeutics, 1995, Volume: 18, Issue:5

    Topics: Absorption; Administration, Oral; Animals; Anti-Infective Agents; Biological Availability; Body Weight; Camelus; Eating; Enrofloxacin; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Quinolones; Water Deprivation

1995
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
    British poultry science, 1998, Volume: 39, Issue:1

    Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Mycoplasma Infections; Nicotinic Acids; Norfloxacin; Poultry Diseases; Probability; Quinolones; Respiratory Tract Infections; Survival Analysis

1998
Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs.
    The Journal of small animal practice, 1999, Volume: 40, Issue:6

    Topics: Animals; Anti-Infective Agents; Body Weight; Cellulitis; Dog Diseases; Dogs; Enzyme Inhibitors; Erythema; Female; Fluoroquinolones; Folliculitis; Follow-Up Studies; Male; Microbial Sensitivity Tests; Pruritus; Pyoderma; Quinolones; Recurrence; Skin Ulcer; Staphylococcal Infections; Treatment Outcome

1999
The effect of organic acids on the control of post-weaning oedema disease of piglets.
    Research in veterinary science, 2001, Volume: 70, Issue:3

    Topics: Animal Feed; Animals; Anti-Infective Agents; Body Weight; Citric Acid; Dietary Supplements; Edema Disease of Swine; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Intestine, Small; Lactic Acid; Male; Quinolones; Swine

2001

Other Studies

57 other study(ies) available for carbostyril and Body Weight

ArticleYear
Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2022, Volume: 21, Issue:2

    Topics: Adult; Aminophenols; Benzodioxoles; Body Weight; Cardiometabolic Risk Factors; Chloride Channel Agonists; Cholesterol; Cystic Fibrosis; Humans; Indoles; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Retrospective Studies

2022
Generation and Application of Inducible Chimeric RNA
    Cells, 2022, 01-14, Volume: 11, Issue:2

    Topics: 4-Nitroquinoline-1-oxide; Animals; Body Weight; Carcinogens; Disease Models, Animal; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Knock-In Techniques; Genotype; Mice; Mice, Inbred C57BL; Mouse Embryonic Stem Cells; Quinolones; RNA, Antisense; Tamoxifen

2022
Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males.
    American journal of respiratory and critical care medicine, 2020, 04-15, Volume: 201, Issue:8

    Topics: Adolescent; Adult; Age Factors; Aminophenols; Body Mass Index; Body Weight; Child; Chloride Channel Agonists; Chlorides; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Male; Quinolones; Sex Factors; Sweat; Young Adult

2020
Nemonoxacin Has Immunoprotective Effects on Reducing Mortality in Lipopolysaccharide-Induced Mouse Sepsis Model.
    Inflammation, 2020, Volume: 43, Issue:6

    Topics: Animals; Body Weight; Cytokines; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Immune System; Inflammation; Interleukin-10; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Myeloid Cells; Neutrophils; Phagocytosis; Quinolones; RAW 264.7 Cells; Sepsis; Spleen; Tumor Necrosis Factor-alpha

2020
Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:8

    Topics: Animals; Blood Glucose; Body Weight; Down-Regulation; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin; Insulin Resistance; Intestine, Small; Liraglutide; Liver; Male; Metabolic Syndrome; Muscle, Skeletal; Pancreas; Quinolones; Rats; Signal Transduction; Thiophenes

2021
Laquinimod treatment in the R6/2 mouse model.
    Scientific reports, 2017, 07-10, Volume: 7, Issue:1

    Topics: Animals; Biomarkers; Body Weight; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Energy Metabolism; Fluorescent Antibody Technique; Gene Expression; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Neurons; PC12 Cells; Quinolones; Rats; Survival Rate

2017
Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice.
    Atherosclerosis, 2013, Volume: 229, Issue:1

    Topics: Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Blood Proteins; Body Weight; Collagen Type I; Enzyme Inhibitors; Farnesyltranstransferase; Female; Kidney Failure, Chronic; Liver; Macrophages; Mevalonic Acid; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Prenylation; Quinolones; Random Allocation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine; Uremia; Vascular Calcification

2013
Prenatal exposure of a novel antipsychotic aripiprazole: impact on maternal, fetal and postnatal body weight modulation in rats.
    Current drug safety, 2014, Volume: 9, Issue:1

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Birth Weight; Body Weight; Eating; Female; Fetal Weight; Male; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Wistar

2014
Sweat chloride is not a useful marker of clinical response to Ivacaftor.
    Thorax, 2014, Volume: 69, Issue:6

    Topics: Aminophenols; Biomarkers; Body Height; Body Weight; Chlorides; Cohort Studies; Cystic Fibrosis; Forced Expiratory Flow Rates; Humans; Lung; Prospective Studies; Quinolones; Spirometry; Sweat

2014
Ivacaftor. Uncertain harm-benefit balance.
    Prescrire international, 2013, Volume: 22, Issue:142

    Topics: Aminophenols; Body Weight; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Interactions; Forced Expiratory Volume; Humans; Quinolones; Randomized Controlled Trials as Topic; Uncertainty

2013
Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta Catenin; Body Weight; Cell Division; Cyclooxygenase 2; Dinoprostone; Female; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Permeability; Proto-Oncogene Proteins c-myc; Quinolones; Random Allocation; Regeneration; RNA, Messenger; Tight Junctions

2015
Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study.
    The international journal of neuropsychopharmacology, 2015, Oct-01, Volume: 19, Issue:3

    Topics: Action Potentials; Animals; Body Weight; Brain; Dopamine; Male; Neurons; Neurotransmitter Agents; Norepinephrine; Psychotropic Drugs; Quinolones; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Serotonin; Thiophenes; Time Factors; Tissue Culture Techniques

2015
Hypothalamic Phosphodiesterase 3B Pathway Mediates Anorectic and Body Weight-Reducing Effects of Insulin in Male Mice.
    Neuroendocrinology, 2017, Volume: 104, Issue:2

    Topics: Animals; Body Weight; Cyclic Nucleotide Phosphodiesterases, Type 3; Eating; Gene Expression; Hypothalamus; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphorylation; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt; Quinolones; Signal Transduction; STAT3 Transcription Factor; Weight Loss

2017
Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, Volume: 24, Issue:2

    Topics: Absorptiometry, Photon; Androgen Antagonists; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Estrogens; Female; Femur; Lumbar Vertebrae; Male; Orchiectomy; Organ Size; Osteocalcin; Ovariectomy; Pyrroles; Quinolones; Rats; Rats, Sprague-Dawley; Transcription, Genetic

2009
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
    Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis

2008
Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Body Mass Index; Body Weight; Female; Humans; Korea; Male; Middle Aged; Piperazines; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Suicide; Young Adult

2009
The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3

    Topics: Acute Disease; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Black or African American; Blood Glucose; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Hispanic or Latino; Humans; Hypercholesterolemia; Male; Metabolic Syndrome; Middle Aged; Obesity; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; White People; Young Adult

2009
Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats.
    Neurochemistry international, 2009, Volume: 55, Issue:7

    Topics: Amino Acid Transport System X-AG; Animals; Antipsychotic Agents; Aripiprazole; Astrocytes; Body Weight; Dose-Response Relationship, Drug; Gene Expression Regulation; Genetic Markers; In Situ Hybridization; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Time Factors; Transcription, Genetic

2009
Aripiprazole for the management of olanzapine-induced weight gain.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Central Nervous System Agents; Cholesterol; Drug Therapy, Combination; Female; Glucose; Humans; Male; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain

2009
Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study.
    Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:1

    Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Body Weight; Cholesterol; Electrocardiography; Female; Follow-Up Studies; Heart; Hormones; Humans; Japan; Male; Middle Aged; Piperazines; Prolactin; Quinolones; Schizophrenia; Triglycerides

2010
Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Body Weight; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Schizophrenic Psychology; Young Adult

2010
A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Mar-30, Volume: 35, Issue:2

    Topics: Age Factors; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Dibenzothiazepines; Female; Humans; Inpatients; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risk; Risk Factors; Risperidone; Schizophrenia; Sex Factors; Time Factors; Weight Gain

2011
Influence of prenatal undernutrition on the effects of clozapine and aripiprazole in the adult male rats: relevance to a neurodevelopmental origin of schizophrenia?
    European journal of pharmacology, 2011, Sep-30, Volume: 667, Issue:1-3

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Body Weight; Clozapine; Disease Susceptibility; Eating; Female; Gene Expression Regulation; Hormones; Hypothalamus; Male; Malnutrition; Nervous System; Obesity; Piperazines; Pregnancy; Prenatal Nutritional Physiological Phenomena; Quinolones; Rats; Rats, Wistar; Schizophrenia

2011
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:2

    Topics: Adipose Tissue; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Female; Gene Expression Regulation; Hyperphagia; Lipid Metabolism; Lipogenesis; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Triglycerides; Weight Gain

2012
Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
    European child & adolescent psychiatry, 2011, Volume: 20, Issue:11-12

    Topics: Adolescent; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Child; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Spain; Time Factors

2011
Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:5

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Body Weight; Clozapine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Quinolones; Risperidone; Schizophrenia; Weight Loss

2012
Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jan-10, Volume: 40

    Topics: Adiponectin; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Female; Humans; Lipids; Male; Middle Aged; Obesity; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quinolones; Weight Gain

2013
Comparative efficacy of enrofloxacin, oxytetracycline, and sulfadimethoxine for the control of morbidity and mortality caused by Escherichia coli in broiler chickens.
    Avian diseases, 2004, Volume: 48, Issue:3

    Topics: Air Sacs; Analysis of Variance; Animals; Anti-Bacterial Agents; Body Weight; Chickens; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Oxytetracycline; Poultry Diseases; Quinolones; Sulfadimethoxine; Treatment Outcome

2004
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
    Psychopharmacology, 2005, Volume: 182, Issue:2

    Topics: Animals; Aripiprazole; Benzodiazepines; Body Weight; Cholesterol, HDL; Fatty Acids, Nonesterified; Female; Olanzapine; Piperazines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Weight Gain

2005
Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
    Journal of psychiatric practice, 2005, Volume: 11, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Mathematical Computing; Middle Aged; Obesity; Piperazines; Product Surveillance, Postmarketing; Psychotic Disorders; Quinolones; Receptors, Dopamine D2; Schizophrenia; Treatment Outcome

2005
The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis.
    European journal of pharmacology, 2006, Aug-07, Volume: 542, Issue:1-3

    Topics: Administration, Oral; Animals; Behavior, Animal; Betamethasone Valerate; Body Weight; Dermatitis, Atopic; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Immunosuppressive Agents; Male; Mice; Mice, Inbred Strains; Pruritus; Quinolones; Receptor, Cannabinoid, CB2; Severity of Illness Index; Skin; Tacrolimus

2006
Aripiprazole in childhood and adolescence for Tourette syndrome.
    Journal of child neurology, 2006, Volume: 21, Issue:4

    Topics: Adolescent; Adolescent Behavior; Adult; Antipsychotic Agents; Aripiprazole; Attention; Body Weight; Child; Child Behavior; Cognition; Dose-Response Relationship, Drug; Humans; Male; Piperazines; Psychomotor Agitation; Quinolones; Tourette Syndrome; Treatment Outcome

2006
Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Weight; Cholesterol; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Retrospective Studies; Schizophrenia; Schizophrenic Psychology

2007
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    Journal of affective disorders, 2007, Volume: 101, Issue:1-3

    Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones

2007
High interstitial fluid pressure in rat tongue cancer is related to increased lymph vessel area, tumor size, invasiveness and decreased body weight.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2008, Volume: 37, Issue:3

    Topics: 4-Nitroquinoline-1-oxide; Analysis of Variance; Animals; Body Weight; Carcinoma, Squamous Cell; Extracellular Fluid; Lymphatic Vessels; Male; Neoplasm Invasiveness; Pressure; Quinolones; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tongue Neoplasms

2008
Inhibition of aldose reductase in five tissues of the streptozotocin-diabetic rat.
    Biochemical pharmacology, 1983, May-01, Volume: 32, Issue:9

    Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Glucose; Kidney; Lens, Crystalline; Male; Organ Size; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Retina; Sciatic Nerve; Seminal Vesicles; Sugar Alcohol Dehydrogenases

1983
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:5

    Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Female; Hypertension; Male; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR

1995
Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1995, Volume: 17, Issue:3

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Desoxycorticosterone; Hypertension; Male; Piperidines; Quinolones; Random Allocation; Rats; Rats, Wistar; Sodium Chloride

1995
Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney; Male; Nephrectomy; Nephrosclerosis; Piperidines; Proteinuria; Quinolones; Rats; Rats, Inbred SHR

1995
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    The American journal of physiology, 1994, Volume: 267, Issue:6 Pt 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium

1994
Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 28, Issue:1

    Topics: Animals; Animals, Newborn; Anti-Infective Agents; Body Weight; Cartilage, Articular; Ciprofloxacin; Female; Foot; Joint Diseases; Mice; Pipemidic Acid; Pregnancy; Quinolones

1995
[A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test].
    The Journal of toxicological sciences, 1996, Volume: 21 Suppl 1

    Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Beta-Globulins; Body Weight; Cartilage, Articular; Dioxolanes; Dogs; Dyskinesia, Drug-Induced; Female; Fluoroquinolones; gamma-Globulins; Male; Piperazines; Quinolones

1996
One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:7

    Topics: Animals; Anti-Infective Agents; Blood Cell Count; Blood Chemical Analysis; Body Weight; Eating; Enzymes; Feces; Female; Fluoroquinolones; Macaca fascicularis; Male; Organ Size; Quinolones; Rats; Rats, Sprague-Dawley; Tissue Distribution

1996
Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:2

    Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Diuretics; Electrolytes; Furosemide; Gene Expression; Heart Rate; Hypertension; Male; Myosin Heavy Chains; Oximes; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Trichlormethiazide

1996
Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.
    Regulatory peptides, 1997, Oct-31, Volume: 72, Issue:2-3

    Topics: Acetylglucosaminidase; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Growth Substances; Heart Rate; Hypertension; Kidney Glomerulus; Organ Size; Piperidines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Proliferating Cell Nuclear Antigen; Proteinuria; Quinolones; Random Allocation; Rats; Rats, Inbred SHR; RNA, Messenger; Sodium; Transforming Growth Factor beta; Urine

1997
A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
    Human & experimental toxicology, 1999, Volume: 18, Issue:1

    Topics: Animals; Anti-Infective Agents; Blood Cells; Body Weight; Eating; Female; Fluoroquinolones; Humans; Infant, Newborn; Joint Diseases; Male; Organ Size; Piperazines; Quinolones; Rats; Survival Rate; Time Factors

1999
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
    Japanese journal of cancer research : Gann, 1999, Volume: 90, Issue:3

    Topics: Administration, Oral; Animals; Body Weight; Collagenases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme Precursors; Gelatinases; Lung Neoplasms; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Molecular Weight; Neoplasm Transplantation; Organ Size; Osteosarcoma; Quinolones; Rats; Rats, Inbred F344; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2

1999
Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments.
    Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B, 1999, Volume: 46, Issue:4

    Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Cephalosporins; Diterpenes; Enrofloxacin; Fluoroquinolones; Lung; Lung Diseases; Penicillins; Quinolones; Swine; Swine Diseases; Weight Gain

1999
Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
    American journal of veterinary research, 1999, Volume: 60, Issue:9

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Area Under Curve; Body Weight; Cattle; Chromatography, High Pressure Liquid; Enrofloxacin; Fluoroquinolones; Half-Life; Injections, Intravenous; Least-Squares Analysis; Mice; Quinolones; Rabbits; Rats; Regression Analysis; Sheep; Ultrafiltration

1999
Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
    Japanese journal of cancer research : Gann, 2000, Volume: 91, Issue:1

    Topics: 4-Nitroquinoline-1-oxide; Animals; Body Weight; Carcinogens; Cattle; Epithelium; Glutathione Transferase; Immunohistochemistry; Lactoferrin; Liver; Male; Mucous Membrane; NAD(P)H Dehydrogenase (Quinone); Organ Size; Ornithine Decarboxylase; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Quinolones; Rats; Rats, Inbred F344; Tongue; Tongue Neoplasms

2000
Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats.
    Archives of toxicology, 2000, Volume: 74, Issue:2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Bone and Bones; Eating; Female; Fetal Death; Fluoroquinolones; Male; Maternal-Fetal Exchange; Piperazines; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Teratogens

2000
Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
    Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:11

    Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Hematocrit; Hypertension; Male; Organ Size; Osmolar Concentration; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Urodynamics

2000
A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding.
    Nature neuroscience, 2002, Volume: 5, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Body Weight; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; DNA; DNA-Binding Proteins; Electrodes, Implanted; Enzyme Activation; Enzyme Inhibitors; Feeding Behavior; Hypothalamus; Injections, Intraventricular; Janus Kinase 2; Leptin; Male; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Quinolones; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Trans-Activators

2002
Effect of enrofloxacin therapy on shipping fever pneumonia in feedlot cattle.
    The Veterinary record, 1988, Aug-20, Volume: 123, Issue:8

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Blood Gas Analysis; Body Weight; Cattle; Enrofloxacin; Fluoroquinolones; Injections, Intramuscular; Male; Pasteurella Infections; Pasteurellosis, Pneumonic; Pneumonia; Quinolones

1988
Reproductive studies of NY-198 in rats. I. Fertility study.
    The Japanese journal of antibiotics, 1988, Volume: 41, Issue:10

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Drinking; Eating; Female; Fertility; Fluoroquinolones; Male; Quinolones; Rats; Salivation

1988
Reproductive studies of NY-198 in rats. II. Teratology study.
    The Japanese journal of antibiotics, 1988, Volume: 41, Issue:10

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Embryonic and Fetal Development; Female; Fetus; Fluoroquinolones; Male; Quinolones; Rats; Reproduction

1988
Reproductive studies of NY-198 in rats. III. Perinatal and postnatal study.
    The Japanese journal of antibiotics, 1988, Volume: 41, Issue:10

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Weight; Drinking; Eating; Embryonic and Fetal Development; Female; Fluoroquinolones; Lactation; Male; Pregnancy; Pregnancy, Animal; Quinolones; Rats; Reproduction

1988